Legend Biotech Corp Financial Assets At Amortised Cost
Legend Biotech Corp (LEGN) had Financial Assets At Amortised Cost of $1.19 billion as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:FinancialAssetsAtAmortisedCost · last filed 2026-03-10
- 2025-12-31: Financial Assets At Amortised Cost $1.19B.
- 2024-12-31: Financial Assets At Amortised Cost $1.25B; Financial Assets At Amortised Cost as first filed $1.25B.
- 2023-12-31: Financial Assets At Amortised Cost $1.47B.
- 2022-12-31: Financial Assets At Amortised Cost $884.44M.
| Period end | Financial Assets At Amortised Cost | Financial Assets At Amortised Cost as first filed |
|---|---|---|
| 2025-12-31 | $1.19B 20-F · filed 2026-03-10 | |
| 2024-12-31 | $1.25B 20-F · filed 2026-03-10 | $1.25B 20-F · filed 2025-03-11 |
| 2023-12-31 | $1.47B 20-F · filed 2025-03-11 | |
| 2022-12-31 | $884.44M 20-F · filed 2024-03-19 | |
| 2021-12-31 | $940.12M 20-F · filed 2023-03-30 | $940.02M 20-F · filed 2022-03-31 |
| 2021-06-30 | $708.45M 6-K · filed 2021-08-23 | |
| 2020-12-31 | $582.04M 20-F/A · filed 2023-02-17 | $581.39M 20-F · filed 2021-04-02 |
| 2019-12-31 | $190.73M 20-F · filed 2021-04-02 |